NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
08/19/2019
Back to search
Official data from USPTO
BIOCELL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
08/19/2019
Classification
Registered
Trademark type
Word
Nice classes
10
Filing date
06/20/1997
Registration date
07/27/1999
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/19/2019
Last transaction
08/19/2019
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
12/07/1987
First use in commerce
12/31/1987
Drawing code
1
Owner type
03
Owner location
Irvine, CA
Law office
L50
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Allergan, Inc.
I. C. (pessoa física)
M. C. (pessoa física)
Representatives
Allergan, Inc.
Technical classification
Nice Classes
Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
mammary implant prosthetic devices
Publications
History of USPTO decisions and trademark events.
30 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
08/19/2019
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08/19/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/19/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/16/2019
E89R
TEAS SECTION 8 & 9 RECEIVED
07/16/2019
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
07/27/2018
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
09/08/2008
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/08/2008
PLGL
ASSIGNED TO PARALEGAL
09/08/2008
E89R
TEAS SECTION 8 & 9 RECEIVED
08/26/2008
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/28/2006
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/28/2006
CFIT
CASE FILE IN TICRS
08/24/2006
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
08/02/2006
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
05/03/2006
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/13/2005
PLGL
ASSIGNED TO PARALEGAL
09/12/2005
815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
07/13/2005
PAPER RECEIVED
07/13/2005
815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
07/08/2005
E815
TEAS SECTION 8 & 15 RECEIVED
07/08/2005
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/23/2005
R.PR
REGISTERED-PRINCIPAL REGISTER
07/27/1999
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
06/11/1998
PUBO
PUBLISHED FOR OPPOSITION
05/12/1998
NPUB
NOTICE OF PUBLICATION
04/10/1998
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/09/1998
CNEA
EXAMINER'S AMENDMENT MAILED
03/05/1998
DOCK
ASSIGNED TO EXAMINER
01/26/1998
Continuous trademark protection
Get notified about every new filing that threatens BIOCELL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.